DM
Therapeutic Areas
Amphastar Pharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| BAQSIMI® (glucagon nasal powder) | Severe Hypoglycemia | Marketed |
| Biosimilar Insulin Aspart | Diabetes | Development / ANDA Filed |
| Biosimilar Insulin Glargine | Diabetes | Development / ANDA Filed |
| Teriparatide Injection | Osteoporosis | Marketed |
| Iron Sucrose Injection | Iron Deficiency Anemia in CKD | Marketed |
| Primatene® MIST | Mild, Intermittent Asthma | Marketed |
| Albuterol Sulfate Inhalation Aerosol | Bronchospasm | Marketed |
| Enoxaparin Sodium Injection | Anticoagulation | Marketed |
Leadership Team at Amphastar Pharmaceuticals
DJ
Dr. Jack Y. Zhang
Co-Founder, President & CEO
WJ
William J. Peters
Chief Financial Officer, Treasurer & Secretary